News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Harvard Medical School and Cellectricon Collaborates Around Whole-Genome RNAi Screening Technology - Cellaxess(R)HT


11/25/2008 11:31:34 AM

GOTHENBURG, Sweden, Nov. 25 /CNW/ - Cellectricon, a leading provider of automated screening solutions for drug discovery, today announced its collaboration with Harvard Medical School, the ICCB-Longwood Screening Facility ("ICCB-L"). Harvard Medical School (ICCB-L) will utilize the Cellaxess(R)HT system, the world's first system for high throughput transfection enabling reagent-free delivery of genetic material to a wide range of biologically relevant cell types.

Read at Canada NewsWire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES